COMPLETED
Advanced technologies for drug discovery and precision medicine
SINERGIA — advanced technologieS for drug dIscovery and precisioN mEdicine: in vitRo modellinG human physiology and diseAse
SINERGIA was a European research and training network dedicated to the development of advanced in vitro models of human physiology and disease for preclinical drug development.
The programme combined complementary technologies and expertise to improve the evaluation of drug efficacy and safety and support precision medicine.
Programme
Horizon 2020 · Marie Skłodowska-Curie Innovative Training Network
Grant
Grant Agreement No. 860715
MTTlab role
Industrial Beneficiary · Scientific Supervision · Research & Training
MTTlab contribution
MTTlab participated in SINERGIA as an industrial beneficiary, contributing preclinical and CRO expertise to the European research and training network.
MTTlab also contributed to the training programme connecting advanced in vitro model development with preclinical validation and industrial drug-development requirements.
Cristina Degrassi participated in the programme as a scientific supervisor.